BackChina Dasheng Biotechnology Company Overview

China Dasheng Biotechnology Company Total Current Liabilities

China Dasheng Biotechnology Company's total current liabilities is $110K.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$107109.00
↑ 137.27% YoYΔ $61966.00 vs prior year quarter

Peer trimmed avg / median

Loading

China Dasheng Biotechnology Company Total Current Liabilities History

Loading

China Dasheng Biotechnology Company vs. peers: Total Current Liabilities Comparison

Loading

China Dasheng Biotechnology Company Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

China Dasheng Biotechnology Company (CDBT) FAQ

As of the most recent data (September 2026), CDBT shows a total current liabilities of $110K. That compares with $45K in the prior-year period — up 137.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CDBT's total current liabilities is now $110K (was $45K) — a 137.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether China Dasheng Biotechnology Company is outperforming or lagging.

Tracking CDBT's total current liabilities over time shows whether China Dasheng Biotechnology Company is scaling, shrinking, or reshaping that part of the business. The current reading is $110K That compares with $45K in the prior-year period — up 137.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has China Dasheng Biotechnology Company's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $110K) with ownership activity and broader fundamentals.

Questions & Answers